Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy

Author:

Lin Hsien‐Hong1,Hsu Shih‐Jer23,Lu Sheng‐Nan4,Chuang Wan‐Long5,Hsu Chao‐Wei6,Chien Rong‐Nan6,Yang Sien‐Sing7,Su Wei‐Wen8,Wu Jaw‐Ching9,Lee Tzong‐Hsi10,Peng Cheng‐Yuan11,Tseng Kuan‐Chiao12,Qin Albert12,Huang Yi‐Wen131415ORCID,Chen Pei‐Jer1617ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine Taipei Tzu Chi Hospital Taipei Taiwan

2. Department of Internal Medicine National Taiwan University Hospital Yunlin Branch Douliu and Huwei Taiwan

3. Hepatology Medical Center, Department of Internal Medicine National Taiwan University Hospital Yunlin Branch Douliu Taiwan

4. Division of Hepatogastroenterology, Department of Internal Medicine Chia‐Yi Chang Gung Memorial Hospital Puzi Taiwan

5. Department of Internal Medicine Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung Taiwan

6. Division of Hepatology, Department of Gastroenterology and Hepatology Linkou Medical Center, Chang Gung Memorial Hospital Taoyuan Taiwan

7. Liver Center, Department of Internal Medicine Cathay General Hospital Medical Center Taipei Taiwan

8. Division of Gastroenterology and Hepatology, Department of Internal Medicine Changhua Christian Hospital Changhua Taiwan

9. Medical Research Department Taipei Veterans General Hospital Taipei Taiwan

10. Division Gastroenterology, Department of Internal Medicine Far‐Eastern Memorial Hospital New Taipei City Taiwan

11. Center for Digestive Medicine, Department of Internal Medicine China Medical University Hospital, and School of Medicine, China Medical University Taichung Taiwan

12. Department of Medical Research PharmaEssentia Corp Taipei Taiwan

13. Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine Taipei Medical University Taipei Taiwan

14. Division of Gastroenterology and Hepatology, Department of Internal Medicine Taipei Medical University Hospital Taipei Taiwan

15. Department of Internal Medicine, School of Medicine National Taiwan University College of Medicine Taipei Taiwan

16. Graduate Institute of Clinical Medicine National Taiwan University College of Medicine Taipei Taiwan

17. Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C

2. Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

3. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

4. WHOGlobal Hepatitis Report 2017 [Internet].World Health Organization. Cited 23 Sep 2020. Available from URL:http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/

5. WHOGlobal Health Sector Strategy on Viral Hepatitis [Internet].World Health Organization. Cited 22 Feb 2021. Available from URL:https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3